Seeing Is Believing
Currently out of the existing stock ratings of Mitchell Kapoor, 139 are a BUY (91.45%), 8 are a HOLD (5.26%), 5 are a SELL (3.29%).
Analyst Mitchell Kapoor, carries an average stock price target met ratio of 31.91% that have a potential upside of 31.41% achieved within 59 days. Previously, Mitchell Kapoor worked at HC WAINWRIGHT.
Mitchell Kapoor’s has documented 298 price targets and ratings displayed on 14 stocks. The coverage was on the Healthcare sector.
Most recent stock forecast was given on HALO, Halozyme Therapeutics at 19-Feb-2025.
Analyst best performing recommendations are on RPHM (RENEO PHARMACEUTICALS).
The best stock recommendation documented was for LEGN (LEGEND BIOTECH CORP) at 4/18/2023. The price target of $66 was fulfilled within 3 days with a profit of $13.76 (26.34%) receiving and performance score of 87.8.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
$36
$-0.01 (-0.03%)
$36
2 years 2 months 25 days ago
(28-Nov-2022)
3/3 (100%)
$0.35 (0.98%)
267
Hold
$36
$-0.01 (-0.03%)
$35
2 years 3 months ago
(22-Nov-2022)
3/4 (75%)
$0.4 (1.12%)
145
Hold
$36
$-0.01 (-0.03%)
2 years 3 months ago
(22-Nov-2022)
1/1 (100%)
$0.4 (1.12%)
48
Hold
$36
$-0.01 (-0.03%)
$30
2 years 3 months ago
(22-Nov-2022)
2/2 (100%)
$0.4 (1.12%)
258
Hold
$36
$-0.01 (-0.03%)
$25
2 years 3 months 1 days ago
(21-Nov-2022)
2/2 (100%)
$0.41 (1.15%)
37
Which stock is Mitchell Kapoor is most bullish on?
Which stock is Mitchell Kapoor is most reserved on?
What Year was the first public recommendation made by Mitchell Kapoor?